Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM38U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,048
Award facts
- Contract value 100% obligated
- $36,047.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,047.51 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) for 60-tablet supplies of Otezla 30 mg on January 12, 2026, with completion scheduled for January 13, 2026. This delivery order was issued without a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The awardee operates as a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), which does business as Amerisourcebergen and serves as the parent organization in the pharmaceutical supply chain.
This delivery order is issued under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide, covering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Otezla (apremilast) is a medication commonly used to treat autoimmune conditions such as plaque psoriasis and psoriatic arthritis, reflecting the broad therapeutic scope of federal pharmaceutical procurement through this vehicle.
Quick answers
Who was awarded contract SPE2DR26FM38U?
SPE2DR26FM38U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FM38U worth?
The government has obligated $36,048 on SPE2DR26FM38U.
Is contract SPE2DR26FM38U an order under another contract?
Yes. SPE2DR26FM38U is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM38U competed?
The extent of competition for SPE2DR26FM38U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award